Non-exclusive rebate agreements for Apixaban medicines under an open-house model

Summary

The procurement concerns non-exclusive rebate agreements for medicines containing Apixaban under Section 130a(8) of Germany’s Social Code Book V, using an open-house participation model. Interested pharmaceutical companies may participate if they meet and accept the participation conditions. There are no individual contract negotiations, and no supply or other exclusivity is granted. Purchase volumes depend on demand and other market factors; no minimum volume is guaranteed. Participation documents are available through the DTVP procurement portal after an access request has been approved by the contracting authority. Submissions and communications are handled electronically. The first deadline for submitting a participation request is 4 November 2026; subsequent deadlines are listed in the submission-deadlines attachment to the tender documents. Agreements end no later than 30 November 2028, although the contracting authority may terminate the procedure earlier. Check the tender documents for the participation conditions and required submissions.